Top

Published in:

01-04-2018 | Invited article

Contrast-enhanced ultrasound of benign liver lesions

Authors: Jessica G. Zarzour, Kristin K. Porter, Hisham Tchelepi, Michelle L. Robbin

Published in: Abdominal Radiology | Issue 4/2018

Abstract

Liver lesions are often incidentally detected on ultrasound examination and may be incompletely characterized, requiring further imaging. Contrast-enhanced ultrasound (CEUS) was recently approved by the Food and Drug Administration in the United States for liver lesion characterization. CEUS has the ability to characterize focal liver lesions and has been shown to be superior to color Doppler and power Doppler ultrasound in the detection of tumor vascularity. Differentiating benign from malignant liver lesions is essential to characterizing liver lesions. The CEUS imaging characteristics of benign liver lesions are reviewed, including hepatic cysts, hemangiomas, focal fat, focal nodular hyperplasia, hepatocellular adenomas, abscesses, and traumatic lesions.

Strobel D, Krodel U, Martus P, Hahn EG, Becker D (2000) Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors. J Clin Ultrasound: JCU 28(1):1–13CrossRefPubMed

Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 34(1):11–29. https://doi.org/10.1055/s-0032-1325499 PubMed

D’Onofrio M, Crosara S, De Robertis R, Canestrini S, Mucelli RP (2015) Contrast-enhanced ultrasound of focal liver lesions. AJR Am J Roentgenol. 205(1):W56–W66. https://doi.org/10.2214/ajr.14.14203 CrossRefPubMed

Nicolau C, Vilana R, Catala V, et al. (2006) Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 186(1):158–167. https://doi.org/10.2214/ajr.04.1009 CrossRefPubMed

Wilson SR, Burns PN (2006) An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 186(5):1401–1412. https://doi.org/10.2214/ajr.04.1920 CrossRefPubMed

Quaia E, Calliada F, Bertolotto M, et al. (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232(2):420–430. https://doi.org/10.1148/radiol.2322031401 CrossRefPubMed

Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR (2008) Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 190(1):58–66. https://doi.org/10.2214/ajr.07.2493 CrossRefPubMed

Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A (2005) Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 78(932):704–707. https://doi.org/10.1259/bjr/88181612 CrossRefPubMed

Lin MX, Xu HX, Lu MD, et al. (2009) Diagnostic performance of contrast-enhanced ultrasound for complex cystic focal liver lesions: blinded reader study. Eur Radiol 19(2):358–369. https://doi.org/10.1007/s00330-008-1166-8 CrossRefPubMed

10.

Corvino A, Catalano O, Setola SV, et al. (2015) Contrast-enhanced ultrasound in the characterization of complex cystic focal liver lesions. Ultrasound Med Biol 41(5):1301–1310. https://doi.org/10.1016/j.ultrasmedbio.2014.12.667 CrossRefPubMed

11.

Catalano O, Sandomenico F, Raso MM, Siani A (2004) Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses. AJR Am J Roentgenol 182(2):447–450. https://doi.org/10.2214/ajr.182.2.1820447 CrossRefPubMed

12.

Lantinga MA, Gevers TJ, Drenth JP (2013) Evaluation of hepatic cystic lesions. World J Gastroenterol 19(23):3543–3554. https://doi.org/10.3748/wjg.v19.i23.3543 CrossRefPubMedPubMedCentral

13.

Lee JY, Choi BI, Han JK, et al. (2002) Improved sonographic imaging of hepatic hemangioma with contrast-enhanced coded harmonic angiography: comparison with MR imaging. Ultrasound Med Biol 28(3):287–295CrossRefPubMed

14.

Dietrich CF, Mertens JC, Braden B, et al. (2007) Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology (Baltimore, Md) 45(5):1139–1145. https://doi.org/10.1002/hep.21615 CrossRef

15.

Sirli RSI, Popescu A, Danila M, et al. (2011) Contrast enhanced ultrasound for the diagnosis of liver hemangiomas in clinical practice. Med Ultrason 13(2):95–101PubMed

16.

Venkatesh SK, Hennedige T, Johnson GB, Hough DM, Fletcher JG (2017) Imaging patterns and focal lesions in fatty liver: a pictorial review. Abdom Radiol (N Y). 42(5):1374–1392. https://doi.org/10.1007/s00261-016-1002-6 CrossRef

17.

Valls C, Iannacconne R, Alba E, et al. (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16(10):2292–2308. https://doi.org/10.1007/s00330-006-0146-0 CrossRefPubMed

18.

Merkle EMNR (2006) Dual gradient-echo in-phase and opposed-phase hepatic mr imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing. Radiographics 26(5):1409–1418CrossRefPubMed

19.

Quinn SF, Gosink BB (1985) Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol 145(4):753–755. https://doi.org/10.2214/ajr.145.4.753 CrossRefPubMed

20.

Jang JK, Jang H-J, Kim JS, Kim TK (2017) Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom Radiol 42(6):1667–1678. https://doi.org/10.1007/s00261-017-1049-z CrossRef

21.

Shiozawa K, Watanabe M, Ikehara T, et al. (2014) Evaluation of hemodynamics in focal steatosis and focal spared lesion of the liver using contrast-enhanced ultrasonography with sonazoid. Radiol Res Pract 2014:604594. https://doi.org/10.1155/2014/604594 PubMedPubMedCentral

22.

Liu LP, Dong BW, Yu XL, et al. (2008) Evaluation of focal fatty infiltration of the liver using color Doppler and contrast-enhanced sonography. J Clin Ultrasound: JCU. 36(9):560–566. https://doi.org/10.1002/jcu.20507 CrossRefPubMed

23.

Maillette de Buy Wenniger, Terpstra V, Beuers U (2010) Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg 27(1):24–31. https://doi.org/10.1159/000268404 CrossRefPubMed

24.

Buetow PC, Pantongrag-Brown L, Buck JL, Ros PR, Goodman ZD (1996) Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Radiographics 16(2):369–388CrossRefPubMed

25.

Bartolotta TV, Taibbi A, Galia M, et al. (2007) Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound. Eur Radiol 17(3):650–661. https://doi.org/10.1007/s00330-006-0432-x CrossRefPubMed

26.

Yen YH, Wang JH, Lu SN, et al. (2006) Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia. Eur J Radiol 60(3):439–444. https://doi.org/10.1016/j.ejrad.2006.06.007 CrossRefPubMed

27.

Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236(1):166–177. https://doi.org/10.1148/radiol.2361040338 CrossRefPubMed

28.

Hussain SM, Terkivatan T, Zondervan PE, et al. (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24(1):3–17 (discussion 8–9). https://doi.org/10.1148/rg.241035050 CrossRefPubMed

29.

Zheng SG, Xu HX, Liu LN, et al. (2013) Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia. Clin Hemorheol Microcirc 55(3):375–389. https://doi.org/10.3233/ch-121652 PubMed

30.

Kong WT, Wang WP, Huang BJ, et al. (2015) Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma. Ultrasound Med Biol 41(4):944–951. https://doi.org/10.1016/j.ultrasmedbio.2014.11.012 CrossRefPubMed

31.

Wang W, Chen LD, Lu MD, et al. (2013) Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT. Eur Radiol 23(9):2546–2554. https://doi.org/10.1007/s00330-013-2849-3 CrossRefPubMed

32.

von Herbay A, Vogt C, Haussinger D (2002) Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med 21(11):1191–1200CrossRef

33.

Roche V, Pigneur F, Tselikas L, et al. (2015) Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence. Eur Radiol 25(1):186–195. https://doi.org/10.1007/s00330-014-3363-y CrossRefPubMed

34.

van den Esschert JW, van Gulik TM, Phoa SS (2010) Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. Digest Surg 27(1):46–55. https://doi.org/10.1159/000268407 CrossRef

35.

Ganeshan D, Szklaruk J, Kundra V, et al. (2014) Imaging features of fibrolamellar hepatocellular carcinoma. Am J Roentgenol 202(3):544–552. https://doi.org/10.2214/AJR.13.11117 CrossRef

36.

Kondo Y (1985) Histologic features of hepatocellular carcinoma and allied disorders. Pathol Annu 20(Pt 2):405–430PubMed

37.

Yoshikawa J, Matsui O, Kadoya M, et al. (1992) Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. J Comput Assist Tomogr 16(2):206–211CrossRefPubMed

38.

Mathieu D, Bruneton JN, Drouillard J, Pointreau CC, Vasile N (1986) Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 160(1):53–58. https://doi.org/10.1148/radiology.160.1.3520655 CrossRefPubMed

39.

Bioulac-Sage P, Rebouissou S, Thomas C, et al. (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology (Baltimore, Md) 46(3):740–748. https://doi.org/10.1002/hep.21743 CrossRef

40.

Katabathina VS, Menias CO, Shanbhogue AK, et al. (2011) Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics 31(6):1529–1543. https://doi.org/10.1148/rg.316115527 CrossRefPubMed

41.

Laumonier H, Cailliez H, Balabaud C, et al. (2012) Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. AJR Am J Roentgenol 199(2):341–348. https://doi.org/10.2214/ajr.11.7046 CrossRefPubMed

42.

Manichon AF, Bancel B, Durieux-Millon M, et al. (2012) Hepatocellular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions. HPB Surg 2012:418745. https://doi.org/10.1155/2012/418745 CrossRefPubMedPubMedCentral

43.

Claudon M, Cosgrove D, Albrecht T, et al. (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)—update 2008. Ultraschall Med 29(1):28–44. https://doi.org/10.1055/s-2007-963785 CrossRefPubMed

44.

Obaro AE, Ryan SM (2015) Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances. Ultrasound (Leeds, England) 23(2):116–125. https://doi.org/10.1177/1742271x15575805 CrossRef

45.

Liu GJLM, Xie XY, Xu HX, et al. (2008) Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions. J. Ultrasound Med 27(4):657–666CrossRefPubMed

46.

Miele V, Buffa V, Stasolla A, et al. (2004) Contrast enhanced ultrasound with second generation contrast agent in traumatic liver lesions. La Radiol Med 108(1–2):82–91

47.

Menichini G, Sessa B, Trinci M, Galluzzo M, Miele V (2015) Accuracy of contrast-enhanced ultrasound (CEUS) in the identification and characterization of traumatic solid organ lesions in children: a retrospective comparison with baseline US and CE-MDCT. La Radiol Med 120(11):989–1001. https://doi.org/10.1007/s11547-015-0535-z CrossRef

48.

Miele V, Piccolo CL, Galluzzo M, et al. (2016) Contrast-enhanced ultrasound (CEUS) in blunt abdominal trauma. Br J Radiol. https://doi.org/10.1259/bjr.20150823

49.

Durkin N, Deganello A, Sellars ME, et al. (2016) Post-traumatic liver and splenic pseudoaneurysms in children: diagnosis, management, and follow-up screening using contrast enhanced ultrasound (CEUS). J Pediatr Surg 51(2):289–292. https://doi.org/10.1016/j.jpedsurg.2015.10.074 CrossRefPubMed

50.

Miele VPC, Galluzzo M, Ianniello S, Sessa B, Trinci M (2016) Contrast-enhanced ultrasound (CEUS) in blunt abdominal trauma. Br J Radiol. 121(5):409–430

51.

Armstrong LB, Paltiel H, Barnewolt C, et al. (2017) Contrast enhanced ultrasound for the evaluation of blunt pediatric abdominal trauma. J Pediatr Surg. https://doi.org/10.1016/j.jpedsurg.2017.03.042

Title: Contrast-enhanced ultrasound of benign liver lesions
Authors: Jessica G. Zarzour
Kristin K. Porter
Hisham Tchelepi
Michelle L. Robbin
Publication date: 01-04-2018
Publisher: Springer US
Published in: Abdominal Radiology / Issue 4/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-017-1402-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Contrast-enhanced ultrasound of benign liver lesions

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Practical advantages of contrast-enhanced ultrasound in abdominopelvic radiology

Ultrasound: novel techniques

How to set up a contrast-enhanced ultrasound service

Contrast-enhanced ultrasound (CEUS) in abdominal intervention

Multiparametric US for scrotal diseases

Machine learning for medical ultrasound: status, methods, and future opportunities

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page